Other Neurology, biomanufacturing start-ups bag UK AI funding PharmaphorumThe first recipients of the UK government's 500 million Sovereign AI fund have been announced, including two life sciences-focused start-ups.OtherNeuroscienceRead full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaphorum The first recipients of the UK government’s 500 million Sovereign AI fund have been announced, including two life sciences-focused start-ups. OtherNeuroscienceRead full story Post navigation Previous: Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decisionNext: Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
